Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-10-07: Reporting owner Smith Kimberly M.; Form 3; Security Stock Options (right to buy); Transaction Holding.
- 2014-06-20: Reporting owner Smith Marcus E.; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-06-20: Reporting owner Kirk Julian P.; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-06-20: Reporting owner St.Clare Christine; Form 4; Security Options to purchase common stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-10-07 holding as of filing | Smith Kimberly M. Officer (Interim CFO/Treas/Secy) | 3 | Stock Options (right to buy) Derivative · Direct | Holding | $4.11 exercise price | 2014-10-07 | ||
| 2014-06-20 | Smith Marcus E. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $4.14 exercise price | 2014-06-24 | |
| 2014-06-20 | Kirk Julian P. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $4.14 exercise price | 2014-06-24 | |
| 2014-06-20 | St.Clare Christine Director | 4 | Options to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $4.14 exercise price | 2014-06-24 | |
| 2014-06-20 | Swirsky Douglas J Director | 4 | Options to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $4.14 exercise price | 2014-06-24 | |
| 2014-06-20 | Moore Kelvin Director | 4 | Options to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $4.14 exercise price | 2014-06-24 | |
| 2014-06-20 | Mazur Marc Director | 4 | Options to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +18,000 18,000 owned after | $4.14 exercise price | 2014-06-24 | |
| 2014-05-23 holding as of filing | Maslowski John Michael Officer (V.P., Scientific Affairs) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $18.75 exercise price | 2014-05-23 | ||
| 2014-05-23 holding as of filing | Maslowski John Michael Officer (V.P., Scientific Affairs) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $15.50 exercise price | 2014-05-23 | ||
| 2014-05-23 holding as of filing | Maslowski John Michael Officer (V.P., Scientific Affairs) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.49 exercise price | 2014-05-23 | ||
| 2014-05-23 holding as of filing | Maslowski John Michael Officer (V.P., Scientific Affairs) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $4.95 exercise price | 2014-05-23 | ||
| 2014-05-23 holding as of filing | Maslowski John Michael Officer (V.P., Scientific Affairs) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $2.94 exercise price | 2014-05-23 | ||
| 2014-01-17 | WEAVER GREGORY L Officer (Chief Financial Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 165,000 owned after | $4.95 exercise price | 2014-01-21 | |
| 2014-01-06 | Sheroff Robert James Officer (See Remarks) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $4.11 exercise price | 2014-01-07 |